Sarfez Pharmaceuticals, Inc.
Small cardiovascular specialty pharmaceutical company focused on improving existing cardio-renal drugs and making them more accessible and affordable. Activities described include formulation platform development for oral and injectable dosage forms, clinical development and regulatory submission activities, partnerships with specialized contract organizations, and use of data analytics and virtual models to reduce development time and cost.
Industries
N/A
Nr. of Employees
small (1-50)
Sarfez Pharmaceuticals, Inc.
Products
Torsemide tablets (extended-duration formulation for edema)
Oral torsemide tablet formulation intended to treat edema associated with heart failure and renal disease; described tablet strengths include 20 mg, 40 mg, and 60 mg with a reported 6–8 hour diuretic duration.
Torsemide tablets (extended-duration formulation for edema)
Oral torsemide tablet formulation intended to treat edema associated with heart failure and renal disease; described tablet strengths include 20 mg, 40 mg, and 60 mg with a reported 6–8 hour diuretic duration.
Services
Controlled provision of product samples to licensed practitioners via a sample request process for clinical use and evaluation.
Coordination and management of alliances with specialized contract development and manufacturing organizations to execute formulation development, manufacturing, and related activities.
Controlled provision of product samples to licensed practitioners via a sample request process for clinical use and evaluation.
Coordination and management of alliances with specialized contract development and manufacturing organizations to execute formulation development, manufacturing, and related activities.
Expertise Areas
- Cardio-renal drug development
- Oral dosage formulation development
- Clinical trial design and execution
- Regulatory submissions and labeling
Key Technologies
- Matrix-based extended-release formulations
- Orally-disintegrating formulations
- Self-emulsifying drug delivery systems
- Oral solid, liquid and injectable dosage forms
News & Updates
Survey study examining the impact of loop diuretic-induced bladder symptoms on patients with heart failure.
Article describing bladder dysfunction associated with short, rapid-acting loop diuretics.
Study evaluating natriuretic effects of torsemide and the impact of duration of action on sodium excretion.
Company materials state progression of a torsemide tablet formulation from laboratory discovery through FDA submission and approval, and publication of full prescribing information.
Survey study examining the impact of loop diuretic-induced bladder symptoms on patients with heart failure.
Article describing bladder dysfunction associated with short, rapid-acting loop diuretics.
Study evaluating natriuretic effects of torsemide and the impact of duration of action on sodium excretion.
Company materials state progression of a torsemide tablet formulation from laboratory discovery through FDA submission and approval, and publication of full prescribing information.